PharmGKB Blog
Friday, June 21, 2013

CPIC publishes guidelines for HLA-B*15:02 Genotype and Carbamazepine Use

›
The Clinical Pharmacogenomics Implementation Consortium (CPIC) has published guidelines for the use of genetic test results for HLA-B*15:02 ...
Thursday, June 13, 2013

Tacrolimus/Cyclosporine Pathways, Pharmacokinetics and Pharmacodynamics

›
We have added two new pathways to our collection, in collaboration with Dr. Christine Staatz from the University of Queensland and Dr. Rama...
Tuesday, June 4, 2013

Novel SNP in CYP2C cluster associated with warfarin dose in African Americans

›
The International Warfarin Pharmacogenetics Consortium (IWPC),  which involves investigators from eight institutions including Stanford Univ...
Tuesday, May 28, 2013

New VIP Summary for CYP2C8

›
A new VIP summary is available for CYP2C8 , a member of the cytochrome P450 family of drug metabolizing enzymes. CYP2C8 accounts for 7% of...
Monday, May 27, 2013

CPIC guidelines for CYP2C19 genotype and clopidogrel therapy: 2013 Update

›
The 2013 update of the CPIC guidelines for CYP2C19 and clopidogrel dosing is now available online, as an accepted article preview. ...
Friday, May 24, 2013

Big Data in Biomedicine

›
PharmGKB Developers and Curators attended the Big Data in Biomedicine conference this week, organized by Stanford University and the Univer...
Friday, May 17, 2013

New name for IL28B gene = IFNL3

›
PharmGKB has updated our gene names that comply with The Human Genome Nomenclature Committee ( HGNC ) approved symbol, approved name, and sy...
‹
›
Home
View web version

Contributors

  • Caroline Thorn, Curator
  • Katrin Sangkuhl
  • Li Gong
  • Mark Woon
  • Mark Woon
  • Michelle Whirl-Carrillo, Director and Co-PI
  • Ryan Whaley, Technical Lead
  • Teri Klein, Co-PI PharmGKB, CPIC, PharmCAT & ClinGen
Powered by Blogger.